Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile

Authors

Institutions

Publication Details

Journal
American Journal of Cardiovascular Drugs
Published
2026-02-13
DOI
https://doi.org/10.1007/s40256-026-00788-7
Primary Topic
Transplantation: Methods and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile

Juliana Giorgi, HEMANK WALIA, Salomon Chamay, Mrunalini Dandamudi et al.
American Journal of Cardiovascular Drugs
Transplantation: Methods and Outcomes
article

Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile

Juliana Giorgi, HEMANK WALIA, Salomon Chamay, Mrunalini Dandamudi, M. Samaniego, Giang Son Arrighini, V Q T Ho
article en

Abstract

No abstract available for this paper.
American Journal of Cardiovascular Drugs
University of Debrecen (HU), Montefiore Medical Center (US), Duke University (US), Universidad Autónoma Metropolitana (MX), Hospital Israelita Albert Einstein (BR), Pontificia Universidad Católica Argentina (AR), Advocate Illinois Masonic Medical Center (US), Hospital Sírio-Libanês (BR), Atlantic Health System (US), University of Bologna (IT)
Good health and well-being
Openalex Percentile: Top 58%
Transplantation: Methods and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile — Juliana Giorgi, HEMANK WALIA, et al. · American Journal of Cardiovascular Drugs (2026) | TGRS Research Map | TGRS